Data / Form D filings / Trevarx Biomedical, Inc.
Trevarx Biomedical, Inc.: Form D filings
Trevarx Biomedical, Inc., a biotechnology company in Philadelphia, PA, filed 3 Form D notices with the SEC between 2019 and 2025. The latest, on August 4, 2025, reports $350,000 sold of a $750,000 offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2929 ARCH STREET, 3RD FLOOR, Philadelphia, PA, 19104
- Phone
- (206) 949-4956
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1783904
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2025 | New notice | $750,000 | $350,000 | $400,000 | 6 | Jul 25, 2025 | sec.gov |
| Sep 20, 2022 | New notice | $500,000 | $500,000 | 10 | Sep 15, 2022 | sec.gov | |
| Aug 8, 2019 | New notice | $850,000 | $650,000 | $200,000 | 11 | Jul 24, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jean Cho | Executive Officer, Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Trevarx Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.